Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Souery

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 30, 2018
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Journal of Affective Disorders|September 6, 2011
Phenomenology of psychotic mood disorders: lifetime and major depressive episode featuresDaniel Souery, Leonardo Zaninotto, Raffaella Calati, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2019
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter studyGernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 6, 2019
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 7, 2016
Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter studyMarkus Dold, Alexander Kautzky, Lucie Bartova, et al.
Journal of Affective Disorders|October 15, 2021
Pregabalin augmentation of antidepressants in major depression - results from a European multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
The International Journal of Neuropsychopharmacology|May 14, 2013
Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd)Eduard Vieta, Jens M Langosch, Maria Luisa Figueira, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 11, 2022
Characterisation of medication side effects in patients with mostly resistant depression in a real-world settingFabio Panariello, Siegfried Kasper, Joseph Zohar, et al.
International Clinical Psychopharmacology|June 10, 2010
The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association studyNeslihan Aygun Kocabas, Carole Faghel, Mara Barreto, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 28, 2015
Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar SampleLeonardo Zaninotto, Daniel Souery, Raffaella Calati, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 30, 2018
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Journal of Affective Disorders|September 6, 2011
Phenomenology of psychotic mood disorders: lifetime and major depressive episode featuresDaniel Souery, Leonardo Zaninotto, Raffaella Calati, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2019
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter studyGernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 6, 2019
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant DepressionGernot Fugger, Markus Dold, Lucie Bartova, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 7, 2016
Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter studyMarkus Dold, Alexander Kautzky, Lucie Bartova, et al.
Journal of Affective Disorders|October 15, 2021
Pregabalin augmentation of antidepressants in major depression - results from a European multicenter studyMarkus Dold, Lucie Bartova, Gernot Fugger, et al.
The International Journal of Neuropsychopharmacology|May 14, 2013
Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd)Eduard Vieta, Jens M Langosch, Maria Luisa Figueira, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 11, 2022
Characterisation of medication side effects in patients with mostly resistant depression in a real-world settingFabio Panariello, Siegfried Kasper, Joseph Zohar, et al.
International Clinical Psychopharmacology|June 10, 2010
The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association studyNeslihan Aygun Kocabas, Carole Faghel, Mara Barreto, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 28, 2015
Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar SampleLeonardo Zaninotto, Daniel Souery, Raffaella Calati, et al.
Pageof 17